Skip to content

Chain Drug Review

WBA beats estimates for Q2 sales and profits

WBA beats estimates for Q2 sales and profits

Walgreens Boots Alliance Inc. topped analysts’ forecasts for second quarter revenue and adjusted earnings. WBA posted adjusted earnings per share of $1.20, well above Wall Street’s predicted 82 cents. Sales of $37.05 billion exceeded the estimated $36.22 billion. The company posted a net loss of $5.

Camber launches generic Gralise

Camber launches generic Gralise

Camber Pharmaceuticals has added gabapentin tablets (generic for Gralise) to its portfolio. Camber already offers gabapentin tablets and capsules (generic for Neurontin). Generics for Gralise and Neurontin are not interchangeable.

CRN challenges constitutionality of New York law

CRN challenges constitutionality of New York law

The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, today announced the filing of a lawsuit challenging the constitutionality of a recently enacted New York law that would restrict consumer access to safe and beneficial

Former Eckerd CEO Stew Turley dies at 89

Former Eckerd CEO Stew Turley dies at 89

Stew Turley, who guided the evolution of Eckerd Corp. for three decades, died last week at his home in Florida after a battle with lymphoma. He was 89. During the course of his tenure at the retailer, which began in 1966 when he was named manager of non-drug operations, Eckerd grew to 2,778

Valdez is COO of Greater Than One

Valdez is COO of Greater Than One

Jason Valdez has been promoted to chief operating officer of Greater Than One, a media marketing and technology agency focused on healthcare. He is responsible for overall operations and ensuring the agency’s mission of building better healthcare experiences for customers.

CVS beats Q4 sales and earnings projections

CVS beats Q4 sales and earnings projections

CVS Health topped analysts’ forecasts for fourth quarter sales and profits, but cut its full year earnings outlook, citing rising medical costs that are hurting the insurance industry. Revenue for the three months ended December 31 climbed 11.9% from the year-ago period to $93.

WBA beats Q1 projections, cuts dividend

WBA beats Q1 projections, cuts dividend

Walgreens Boots Alliance topped Wall Street’s expectations for first quarter sales and earnings, but slashed its quarterly dividend nearly in half. WBA cut its dividend to 25 cents per share from 48 cents per share, reducing the payout for the first time in nearly five decades.